Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1979-03-23
1981-03-17
Love, Ethel G.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
536 53, 560251, A61K 4904
Patent
active
042567297
ABSTRACT:
Novel X-ray contrast agents, i.e., N,N'-bis-(2,3-dihydroxypropyl)-2,4,6-triiodo-5-(2-keto-L-gulonamido)isopht halamide, and intermediates.
REFERENCES:
patent: 3666760 (1972-05-01), Ackerman
patent: 3701771 (1972-10-01), Almen et al.
patent: 3770820 (1973-11-01), Ackerman
patent: 4001323 (1977-01-01), Felder et al.
patent: 4125599 (1978-11-01), Wiegert
Chem. Abstracts 85:94103 r.
Chem. Abstracts 87:136300 b (German Offen. 2643841, 4-7-77, pp. 26-28 pertinent).
Chem. Abstracts 83:114021 b.
Chem. Abstracts 88:33890 k.
Chem. Abstracts 88:23337 w.
Love Ethel G.
Mallinckrodt Inc.
LandOfFree
N,N'-Bis-(2,3-dihydroxypr opyl)-2,4,6-triiodo-5-(2-keto-L-gulona does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N,N'-Bis-(2,3-dihydroxypr opyl)-2,4,6-triiodo-5-(2-keto-L-gulona, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N,N'-Bis-(2,3-dihydroxypr opyl)-2,4,6-triiodo-5-(2-keto-L-gulona will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1645969